BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14311922)

  • 21. [Dynamics of the total left ventricular systole under the influence of cardiac glycosides with particular reference to proscillaridin A].
    Adamska-Dyniewska H
    Pol Tyg Lek; 1969 Oct; 24(40):1523-5. PubMed ID: 5365667
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the therapy of heart insufficiency with the pure glycoside Proscillaridin A].
    Lampe W; Tergau G
    Med Welt; 1966 Apr; 18():1034-9. PubMed ID: 5955405
    [No Abstract]   [Full Text] [Related]  

  • 23. [Observations on the use of proscillaridin A in some disorders of cardiac rhythm].
    Greco M
    Clin Ter; 1967 Jun; 41(6):555-60. PubMed ID: 5629057
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experiences with a squill preparation (proscillaridin A) in oral administration].
    Rosini E; Petacchi R
    Minerva Med; 1967 Dec; 58(96):4301-18. PubMed ID: 6083292
    [No Abstract]   [Full Text] [Related]  

  • 25. [Proscillaridin A in the therapy of decompensated heart diseases].
    Vigna L; Mollica G
    Minerva Cardioangiol; 1968 Oct; 16(10):987-90. PubMed ID: 5750066
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical notes on the effect of a new cardiokinetic drug (proscillaridin A)].
    Muzio L
    Minerva Med; 1966 May; 57(43 Suppl):2005-6. PubMed ID: 5944828
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experience with proscillaridin A in cardiac insufficiency].
    Feiks FK
    Wien Med Wochenschr; 1966 Mar; 116(11):237-8. PubMed ID: 5985916
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapeutic examination of proscillaridin A].
    Butzengeiger KH; Graeber U; Lange J; Schumacher R
    Dtsch Med Wochenschr; 1967 Dec; 92(48):2212-7. PubMed ID: 6057151
    [No Abstract]   [Full Text] [Related]  

  • 29. [The use of proscillaridin A in the therapy of cardiac insufficiency in the aged].
    Castrucci D; Morini PL
    Minerva Med; 1967 Nov; 58(91):3917-21. PubMed ID: 6081708
    [No Abstract]   [Full Text] [Related]  

  • 30. [Value of the clinical use of proscillaridin A].
    Ratti G; Rocca F; Savastano A
    Clin Ter; 1966 Sep; 38(5):413-24. PubMed ID: 5993561
    [No Abstract]   [Full Text] [Related]  

  • 31. [A year of clinical experience with a new cardio-active glycoside, proscillaridin].
    Pezzo G; Barbera G
    Clin Ter; 1967 May; 41(4):357-61. PubMed ID: 5614305
    [No Abstract]   [Full Text] [Related]  

  • 32. [Some clinical observations on the use of a cardiokinetic extract of squill: proscillaridin A. Differences from other more commonly used glycosides].
    Luise A
    Minerva Med; 1967 Dec; 58(96):4286-9. PubMed ID: 6083290
    [No Abstract]   [Full Text] [Related]  

  • 33. [Acyl and alkyl derivatives of proscillaridin].
    Kubinyi H; Görlich B; Steidle W
    Planta Med; 1971; ():Suppl 4:127-31. PubMed ID: 5170550
    [No Abstract]   [Full Text] [Related]  

  • 34. [On heart therapy using Talusin].
    Fischer J
    Wien Med Wochenschr; 1967 Mar; 117(9):222-5. PubMed ID: 5588776
    [No Abstract]   [Full Text] [Related]  

  • 35. [The use of a new cardioactive glucoside: Proscillaridin A, in the treatment of cardiopathy in the aged].
    Massoni G
    G Gerontol; 1967 Apr; 15(4):565-72. PubMed ID: 5605011
    [No Abstract]   [Full Text] [Related]  

  • 36. Dual effects of ouabain, digoxin and proscillaridin A on the regulation of apoptosis in human fibroblasts.
    Winnicka K; Bielawski K; Bielawska A; Miltyk W
    Nat Prod Res; 2010 Feb; 24(3):274-85. PubMed ID: 20140806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [REPORT ON CLINICO-THERAPEUTIC EXPERIENCES WITH A NEW ORALLY ADMINISTERED CARDIAC GLYCOSIDE].
    WIEDEMANN E
    Hippokrates; 1964 Oct; 35():771-4. PubMed ID: 14325442
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical experience with a new cardioactive glycoside: Proscillaridin A].
    Paron R
    Policlinico Med; 1966 Jun; 73(3):139-81. PubMed ID: 5964916
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the effectiveness of proscillaridin A as deduced from the study of cardiac output in patients with myocardiosclerosis].
    Boni F; Vegro A
    Minerva Med; 1967 Dec; 58(96):4262-7. PubMed ID: 6083287
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical experimentation with a new cardioactive glycoside derived from Scilla: proscillaridin].
    Barbanti G; Legnani L
    Minerva Cardioangiol; 1966 Mar; 14(3):165-9. PubMed ID: 5937432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.